title: Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
abstract: BACKGROUND
  Chemotherapy of bacterial keratitis requires frequent application of antibiotic drops. Collagen shields containing antibiotics could reduce the need for frequent antibiotic application. To determine the effect of gentamicin-containing collagen shields and gentamicin drops on Pseudomonas keratitis, a new keratotomy model of infection was employed.
  
  
  METHODS
  Model--contact lenses (58% water content) presoaked in 1% bovine serum albumin and exposed to 10(8) colony forming units per mL of Pseudomonas aeruginosa strain 27853, were found to reproducibly retain 5.9 (log base 10) colony-forming units. Rabbit corneas were scarified centrally with two perpendicular intersecting diamond knife cuts (5 mm x 5 mm x 0.2 mm), and bacteria-impregnated contact lenses were positioned and held in place for 24 hours with partial tarsorrhaphies. Treatment--Fourteen hours after lens removal (38 hours after infection), corneas were treated for 8 hours with collagen shields hydrated in saline (control), or shields impregnated with 800 micrograms gentamicin during manufacture, or one drop every 30 minutes of fortified gentamicin drops (14 mg/mL). The rabbits were killed and corneas collected for bacterial enumeration after 8 hours of treatment (46 hours after infection).
  
  
  RESULTS
  Model--Slit-lamp examination and microbiologic confirmation showed uniformity of keratitis in all eyes. Treatment--Corneas treated with saline (controls) contained 6.4 (log base 10) Pseudomonas. Corneas treated with gentamicin-impregnated collagen shields (total drug = 800 micrograms) and fortified gentamicin drops (total drug = 21 mg) showed a reduction in viable bacteria of 2 logs and 6 logs, respectively, relative to the control.
  
  
  CONCLUSIONS
  In this new model of Pseudomonas keratitis, the amount of gentamicin introduced into collagen shields during manufacture effectively reduced bacterial growth in infected rabbit corneas. However, larger amounts of drug applied as fortified drops on a frequent dosing schedule were more effective by a factor of three. Treatment of keratitis with antibiotic-impregnated collagen shields may reduce the need for very frequent application of topical drops, but may be more effective with topical drop supplementation to increase the amount of drug available over the course of therapy.
authors.affiliation: LSU Eye Center, New Orleans 70112-2234.
authors.forename: E B
authors.initials: EB
authors.lastname: Brockman
authors.forename: P A
authors.initials: PA
authors.lastname: Tarantino
authors.forename: J A
authors.initials: JA
authors.lastname: Hobden
authors.forename: J M
authors.initials: JM
authors.lastname: Hill
authors.forename: R J
authors.initials: RJ
authors.lastname: O'Callaghan
authors.forename: H E
authors.initials: HE
authors.lastname: Kaufman
authors.forename: M S
authors.initials: MS
authors.lastname: Insler
mesh_terms: D000287:Administration, Topical; D000818:Animals; D001684:Biological Dressings; D003094:Collagen; D015169:Colony Count, Microbial; D003261:Contact Lenses; D003315:Cornea / Q000382:microbiology; D003320:Corneal Ulcer / Q000188:drug therapy / Q000382:microbiology*; D004195:Disease Models, Animal; D004337:Drug Carriers; D015818:Eye Infections, Bacterial / Q000188:drug therapy*; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011817:Rabbits
chemical_list: D004337:Drug Carriers; D005839:Gentamicins; D003094:Collagen